Hepatocellular-cholangiocarcinoma with sarcomatous change: Clinicopathological features and outcomes

doi:10.1016/j.hbpd.2021.03.011

Abstract
Figure/Table
References (0)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a rare type of cancer, accounting for 0.4%-14.2% of hepato-carcinoma. Hepatic sarcoma is only less than 2% of primary malignant liver tumors. Thus, sarcomatoid cHCC-CCA is extremely rare. To the best of our knowledge, only twenty-six cases had been reported in the literature [1-19]. Consensus cannot be reached due to the difficulty of preoperative pathological diagnosis and disagreement for the selection of the treatment. Therefore, clinicopathological features and outcome data about sarcomatoid cHCC-CCA are essential for diagnosis and treatment. We reported in this article three cases with clinical data and prognostic analysis, and summarized 26 cases of sarcomatoid cHCC-CCA from published literatures.

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles in this journal by
	Qian YR
	Jiang N
	Liu P
	Zhang XF
	Liu XM
	Lv Y
	Xiang JX

Cite this article:

Qian YR, Jiang N, Liu P, et al. Hepatocellular-cholangiocarcinoma with sarcomatous change: Clinicopathological features and outcomes. Hepatobiliary Pancreat Dis Int 2021; 20(6): 574-578. DOI:10.1016/j.hbpd.2021.03.011

URL:

http://dx.doi.org/10.1016/j.hbpd.2021.03.011 OR http://www.hbpdint.com/EN/Y2021/V20/I6/574